Skip to content
NB
Company

Updated:

Nascent Biotech Inc.

Nascent Biotech Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001622057, and its reported industry is...

Overview

Nascent Biotech Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001622057, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-07-01, it reported net income of USD -2,087,682; total assets of USD 552,120 for the fiscal period ended 2024-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Nascent Biotech Inc.
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
North Palm Beach, FL, United States
Incorporated in
NV
Fiscal year end
March 31
SEC CIK
0001622057

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsOperating cash flow
FY2024USD—-$2.1M$552,120-$1.2M
FY2023USD$0-$2.8M$255,002-$1.8M
FY2022USD$1.0M-$470,390$105,414$413,479
FY2021USD$750,000-$958,767$751,435-$986,784

FY2021. Operating cash flow: shown as originally filed; later filings report different values for the same periods.

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
10-QFORM 10-Q
10-KFORM 10-K
S-1—FORM S-1
10-QFORM 10-Q
8-KFORM 8-K
10-QFORM 10-Q
8-KFORM 8-K
10-QFORM 10-Q
8-KFORM 8-K
10-K/AFORM 10-K/A
10-KFORM 10-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Nascent Biotech Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles